Latest
Wilmot Science Moves out of the Lab into a Clinical Trial
Laura Calvi, M.D., achieved what a lot of translational researchers only dream of: For years, she made important discoveries in the lab, but then she was able to turn the project into a clinical ...
Sometimes Tumors Vanish, but Improvements Still Needed for CAR T-Cell Immunotherapy
Patrick Reagan, M.D., looks at the data on his computer screen and a rare grin spreads across his face. His most recent study results for patients with end-stage mantle cell lymphoma show that an ...
CAR T-cell Therapy: 'Research and Amazing Medicine'
In autumn of 2017, Nicole Zaleski-Conine experienced side effects she chalked up to a host of reasons, but in January 2018, the definitive diagnosis came in: follicular lymphoma that transformed into ...
CAR T-cell Therapy: Finally, a Milestone to Celebrate
Maxine and Dave Wilson finish each other’s sentences. They feel blessed to have each other, given what Maxine has been through. Then, Maxine was unexpectedly diagnosed with non-Hodgkin lymphoma in ...
CAR T-cell Therapy: The Doctor is a Patient
Patrick Brophy, M.D., physician-in-chief at UR Medicine Golisano Children’s Hospital, says he never looked at his own medical chart. But he knew his health was declining rapidly.
Navigating Telemedicine in Cancer Care
Telemedicine may be one of the positive legacies of the COVID crisis. At Wilmot, a team of doctors, nurses and administrative staff moved quickly to get providers and patients online. By the time the ...
Face to Face: Paula Cupertino on Finding Community and Eliminating Health Disparities
As Wilmot Cancer Institute’s first Associate Director of Community Outreach, Engagement and Disparities, Paula Cupertino, Ph.D., came to Rochester knowing that she had big challenges ahead.
Fresh Faces, New Energy: Transforming Research at Wilmot
Wilmot Cancer Institute leadership has enlisted bright minds from across the nation to come here, to Rochester, as part of a team that pledges to defeat cancer.
Fresh Faces, New Energy: Patrick Murphy, Ph.D.
Working with zebrafish, Patrick Murphy, Ph.D., wants to understand some of the most fundamental questions in cancer including how cells divide and change inappropriately.
Fresh Faces, New Energy: Stephano Mello, Ph.D.
Stephano Mello, Ph.D., has always lived for those “eureka” moments in the lab, but it was a series of personal eureka moments that shifted him toward cancer research.